#cirrhosis

People with liver disease who took fewer steps per day counts were more likely to require hospitalization.

Universal HCV testing led to an increase in the number of pregnant women and infants diagnosed in a timely manner.

Latino individuals are at higher risk for NAFLD, but Black people with NAFLD are more likely to develop cirrhosis.

Noninvasive imaging may be the best way to screen for NAFLD in this population.

A majority of people with alcohol-related liver cirrhosis may have normal ALT levels.

Abdominal obesity worsened the impact of air pollution on MAFLD development.

The PreHevbrio vaccine produces higher antibody levels and offers faster protection.

Fatty liver disease dominated the Hep science news this year, but COVID-19 remains a concern for people with liver disease.

Sofosbuvir-based regimens were well tolerated and cure rates were high in this population.

The drug, which blocks entry of HBV into liver cells, also prevents HDV replication.

People with fatty liver disease and obesity who underwent bariatric surgery had better clinical outcomes.

Hepatocellular carcinoma can still occur after hepatitis C is cured, and risk factors differ for people with and without cirrhosis.

Heavy alcohol use during the pandemic was linked to a rise in waiting list registrations and transplants due to alcohol-related hepatitis.

Over the next two decades, obesity-linked NASH will lead to more deaths and high cost in the United States.

People with HIV had fewer cirrhosis-related complications but greater healthcare utilization.

Advanced stages of NAFLD were more commonly seen in people whose mothers had obesity or overweight during pregnancy.